MARÍA JOSÉ
PARELLADA REDONDO
Profesora titular de universidad
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (47)
2024
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
Revista de Psiquiatria y Salud Mental
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes
World Journal of Biological Psychiatry, Vol. 23, Núm. 3, pp. 208-218
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
-
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176
2020
-
Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness
Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 846-856
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2019
-
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
Psychological Medicine
-
Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis
Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 846-858
2018
-
Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis
Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455
-
Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis
European Child and Adolescent Psychiatry, Vol. 27, Núm. 1, pp. 113-126